Loading, please wait ...


News Analytics

1585186699299.
Anyone interested in Nektar Therapeutics (NASDAQ:NKTR) should probably be aware that the CEO, President & Director, Howard Robin, recently divested US$144k worth of shares in the company, at an average price of US$3.95 each. The eyebrow raising move amounted to a reduction of 12% in their holding.

The Angle

Subject Matter

  • Business, economics, society 100.00%
    • Companies, industries, organizations 100.00%

Emotional Reaction

Sentiment

Positive

Neutral

Negative

Definitions

Depth Chart

Here we provide depth for the multitude of dimensions lacing this article.

Connect your favorite information below with the lead sentence at the top of the page to build a mental model of the story.